Concepedia

Hiroaki Ozasa

HO

Statistics

Publications

37

Citations

1.5K

H-Index

22

Active since

2007

Affiliations

Kyoto University(Current)

Nagoya City University

Kyoto University Hospital

Mizuho (Japan)

Kindai University

Hiroaki Ozasa is an author at Kyoto University specializing in medicine, lung cancer, and oncology.

ORCID

Top concepts

Publications per year

2007–2024

37

Publications

37

MRP8/ABCC11 directly confers resistance to 5-fluorouracil

Tetsuya Oguri, Yuji Bessho, Hiroyuki Achiwa et al. · Molecular Cancer Therapeutics · 2007 · 130 citations

Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients

Takashi Nomizo, Hiroaki Ozasa, Takahiro Tsuji et al. · Scientific Reports · 2017 · 117 citations · Full text

Significance of thymidylate synthase for resistance to pemetrexed in lung cancer

Hiroaki Ozasa, Tetsuya Oguri, Takehiro Uemura et al. · Cancer Science · 2009 · 114 citations · Full text

, , +13

Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy

Ryusuke Hatae, Kenji Chamoto, Young Hak Kim et al. · JCI Insight · 2019 · 87 citations · Full text

, , +22

A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)

Shoichi Hazama, Yusuke Nakamura, Hiroaki Tanaka et al. · Journal of Translational Medicine · 2014 · 86 citations · Full text

1–5 of 37